The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules.

作者: Beatriz Torre , Fernando Albericio

DOI: 10.3390/MOLECULES22030368

关键词: DrugChemistryDrug approvalPharmacologySmall moleculePharmaceutical industry

摘要: … This report analyzes the 53 new drugs of the 2020 harvest … ADC, three more peptides and two oligonucleotides received … of the new drugs authorized this year by the FDA are TIDES. …

参考文章(11)
Aikaterini A Zompra, Athanassios S Galanis, Oleg Werbitzky, Fernando Albericio, Manufacturing peptides as active pharmaceutical ingredients. Future Medicinal Chemistry. ,vol. 1, pp. 361- 377 ,(2009) , 10.4155/FMC.09.23
Vincent Guerlavais, Damien Boeglin, Delphine Mousseaux, Catherine Oiry, Annie Heitz, Romano Deghenghi, Vittorio Locatelli, Antonio Torsello, Corrado Ghé, Filomena Catapano, Giampiero Muccioli, Jean-Claude Galleyrand, Jean-Alain Fehrentz, Jean Martinez, New Active Series of Growth Hormone Secretagogues Journal of Medicinal Chemistry. ,vol. 46, pp. 1191- 1203 ,(2003) , 10.1021/JM020985Q
Miriam Góngora-Benítez, Judit Tulla-Puche, Fernando Albericio, Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs Future Medicinal Chemistry. ,vol. 5, pp. 291- 300 ,(2013) , 10.4155/FMC.13.5
Haidan Yuan, Qianqian Ma, Li Ye, Guangchun Piao, The Traditional Medicine and Modern Medicine from Natural Products. Molecules. ,vol. 21, pp. 559- ,(2016) , 10.3390/MOLECULES21050559
Alain Beck, Liliane Goetsch, Charles Dumontet, Nathalie Corvaïa, Strategies and challenges for the next generation of antibody–drug conjugates Nature Reviews Drug Discovery. ,vol. 16, pp. 315- 337 ,(2017) , 10.1038/NRD.2016.268
Yahya E. Jad, Ayman El-Faham, Beatriz G. de la Torre, Fernando Albericio, CHAPTER 18:Solid-Phase Peptide Synthesis, the State of the Art: Challenges and Opportunities pp. 518- 550 ,(2017) , 10.1039/9781788011532-00518
Asher Mullard, 2016 FDA drug approvals Nature Reviews Drug Discovery. ,vol. 16, pp. 73- 76 ,(2017) , 10.1038/NRD.2017.14
Asher Mullard, 2017 FDA drug approvals. Nature Reviews Drug Discovery. ,vol. 17, pp. 81- 85 ,(2018) , 10.1038/NRD.2018.4
Why can’t the drug industry solve its gender diversity problem? Chemical & Engineering News. ,vol. 96, pp. 26- 33 ,(2018) , 10.1021/CEN-09610-COVER